(Burton, Michigan) — May 21, 2013: The Alzheimer’s Art Quilt Initiative (AAQI) has awarded a $60,000 grant to Mount Sinai School of Medicine to study a drug which may decrease the production of amyloid in the brain and increase the “birth” of new brain cells. The drug is currently being tested in humans for other conditions. Should the AAQI-funded study show promising results in mice, it is hoped the drug can be tested in Alzheimer’s patients.
The research will be carried out by Dr. Michelle E. Ehrlich, professor of Pediatrics, Neurology, and Genetics and Genomic Sciences at the Mount Sinai School of Medicine in New York City.
This is the 15th grant the Alzheimer’s Art Quilt Initiative has awarded since it began in 2006 and the 4th grant award this year. These grants are made possible, in large part, by the money raised from the sale of donated quilts. To support the AAQI’s mission by purchasing a quilt, visit www.alzquilts.org/quiltsforsale.html
A small wall quilt stitched by AAQI Board member Kathy Kennedy-Dennis of Houston, TX was presented to Dr. Erlich on behalf of the Alzheimeimer’s Art Quilt Initiative by quilter Paula Nadelstern of New York, NY. Please see AAQI Update Blog for more details about the quilt presentation.
The Alzheimer’s Art Quilt Initiative is a national charity whose mission is to raise awareness and fund research. The AAQI has raised more than $916,000 for Alzheimer’s research since January 2006. Ami Simms of Flint, Michigan is the founder and executive director of the AAQI, a 501(c)(3) nonprofit organization. Her mother had Alzheimer’s. This is the last year the AAQI will be fundraising.